Ginkgo Bioworks Holdings Q2 2024 GAAP EPS $(0.11) Misses $(0.07) Estimate, Sales $56.21M Beat $43.14M Estimate
Ginkgo Bioworks Holdings Q2 2024 GAAP EPS $(0.11) Misses $(0.07) Estimate, Sales $56.21M Beat $43.14M Estimate
Ginkgo Bioworks Holdings 2024年第二季度的營業額爲5621萬美元，超過預期的4314萬美元。每股收益爲$(0.11)，低於預期的$(0.07)。
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.07) by 57.14 percent. The company reported quarterly sales of $56.21 million which beat the analyst consensus estimate of $43.14 million by 30.30 percent. This is a 30.24 percent decrease over sales of $80.57 million the same period last year.
Ginkgo Bioworks Holdings（紐交所：DNA）報告每股虧損0.11美元，比分析師共識預期的0.07美元虧損率高達57.14％。該公司報告季度銷售額爲5621萬美元，比分析師共識預期的4314萬美元高出30.30％。這是自去年同期銷售額爲8057萬美元以來的下降30.24％。
資訊熱榜
更新時間